Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome

European Journal of Clinical Pharmacology

Volumn 69, Issue 10, 2013, Pages 1861-1862

  Hou, Qian ^a,b   Han, Weidong ^a   Fu, Xiaobing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b The Endovascular Interventional Treatment Center of Chinese Peoples Liberation Army   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CREATININE; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; MULTIDRUG RESISTANCE PROTEIN 1; PREDNISONE; TACROLIMUS;

ADOLESCENT; CASE REPORT; CREATININE BLOOD LEVEL; DIARRHEA; DNA POLYMORPHISM; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; ENZYME IMMUNOASSAY; GENERALIZED EDEMA; GENOTYPE; HOMOZYGOSITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; RELAPSE;

ADOLESCENT; ANTIDIARRHEALS; BERBERINE; CREATININE; HERB-DRUG INTERACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEPHROTIC SYNDROME; TACROLIMUS;

EID: 84884819192     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1537-1     Document Type: Letter

References (4)

1. Vuddanda PR, Chakraborty S, Singh S (2010) Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs 19(10):1297-1307
2. Wallemacq P, Armstrong VW, Brunet M et al (2009) Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit 31(2):139-152
3. Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH (2012) Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol 68(2):213-217
4. Wu X, Li Q, Xin H, Yu A, Zhong M (2005) Effects of berberine on the blood concentration of cyclosporine A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol 61(8):567-572